168 related articles for article (PubMed ID: 24688106)
41. Testicular double-hit lymphoma in a patient with history of follicular lymphoma with high proliferation index.
Chung BM; Zieske AW
Blood; 2018 Apr; 131(16):1874. PubMed ID: 29674355
[No Abstract] [Full Text] [Related]
42. Unusual Variants of Follicular Lymphoma: Case-based Review.
Chapman JR; Alvarez JP; White K; Sanchez S; Khanlari M; Algashaamy K; Cassidy D; Peng JH; Fan YS; Alencar A; Alderuccio JP; Lossos IS; Vega F
Am J Surg Pathol; 2020 Mar; 44(3):329-339. PubMed ID: 31688142
[TBL] [Abstract][Full Text] [Related]
43. CD44 expression during tumor progression of follicular lymphoma.
Higashi M; Sugaya Y; Soeta S; Yokota A; Ishii G; Harigaya K
Oncol Rep; 2009 Nov; 22(5):1135-40. PubMed ID: 19787231
[TBL] [Abstract][Full Text] [Related]
44. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from the microscope.
Harris NL
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):158-62. PubMed ID: 25696849
[TBL] [Abstract][Full Text] [Related]
45. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Olsen ML; Funder AM; d'Amore F
Leuk Lymphoma; 2007 Mar; 48(3):584-95. PubMed ID: 17454603
[TBL] [Abstract][Full Text] [Related]
46. Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.
Mozas P; Rivero A; Rivas-Delgado A; Fabregat A; Piñeyroa JA; Correa JG; Nadeu F; Oliver A; Bataller A; Giné E; Delgado J; Villamor N; Cibeira MT; Fernández de Larrea C; Rosiñol L; Campo E; Aróstegui JI; Bladé J; Magnano L; López-Guillermo A
Br J Haematol; 2021 Apr; 193(2):299-306. PubMed ID: 33200406
[TBL] [Abstract][Full Text] [Related]
47. Follicular lymphoma of the salivary gland: a clinicopathological and molecular study of six cases.
Kojima M; Nakamura S; Ichimura K; Shimizu K; Itoh H; Masawa N
Int J Surg Pathol; 2001 Oct; 9(4):287-93. PubMed ID: 12574844
[TBL] [Abstract][Full Text] [Related]
48. The utility of IgM, CD21, HGAL and LMO2 in the diagnosis of pediatric follicular lymphoma.
Karnik T; Ozawa MG; Lefterova M; Luna-Fineman S; Alvarez E; Link M; Zehnder JL; Arber DA; Ohgami RS
Hum Pathol; 2015 Apr; 46(4):629-33. PubMed ID: 25701230
[TBL] [Abstract][Full Text] [Related]
49. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
50. Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.
Clear AJ; Lee AM; Calaminici M; Ramsay AG; Morris KJ; Hallam S; Kelly G; Macdougall F; Lister TA; Gribben JG
Blood; 2010 Jun; 115(24):5053-6. PubMed ID: 20375314
[TBL] [Abstract][Full Text] [Related]
51. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
Boughan KM; Caimi PF
Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
[TBL] [Abstract][Full Text] [Related]
52. Colocalization of BCL2-positive and -negative follicular lymphoma.
Laurent C; Brousset P
Leukemia; 2014 Jun; 28(6):1368-70. PubMed ID: 24463470
[No Abstract] [Full Text] [Related]
53. Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.
Mamessier E; Drevet C; Broussais-Guillaumot F; Mollichella ML; Garciaz S; Roulland S; Benchetrit M; Nadel B; Xerri L
Haematologica; 2015 Apr; 100(4):e155-7. PubMed ID: 25527563
[No Abstract] [Full Text] [Related]
54. B-cell lymphoma with pseudopapillary features, myxoid changes and lack of CD20 expression: a diagnostic pitfall.
Raciti P; Allen A; Mears G; Bhagat G; Alobeid B
Leuk Lymphoma; 2015; 56(11):3213-5. PubMed ID: 25747969
[No Abstract] [Full Text] [Related]
55. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
[TBL] [Abstract][Full Text] [Related]
56. The challenge of the microenvironment in B-cell lymphomas.
Coupland SE
Histopathology; 2011 Jan; 58(1):69-80. PubMed ID: 21261684
[TBL] [Abstract][Full Text] [Related]
57. Sclerosing variant of follicular lymphoma arising from submandibular glands and resembling "Küttner tumor": a report of 3 patients.
Kojima M; Nakamura S; Itoh H; Yamane Y; Tanaka H; Sugihara S; Sakata N; Masawa N
Int J Surg Pathol; 2003 Oct; 11(4):303-7. PubMed ID: 14615825
[TBL] [Abstract][Full Text] [Related]
58. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
Araujo-Ayala F; Pérez-Galán P; Campo E
Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
[TBL] [Abstract][Full Text] [Related]
59. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.
Katzenberger T; Kalla J; Leich E; Stöcklein H; Hartmann E; Barnickel S; Wessendorf S; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
Blood; 2009 Jan; 113(5):1053-61. PubMed ID: 18978208
[TBL] [Abstract][Full Text] [Related]
60. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
